Planning

Prior Information Notice - Licence Variation for Anastrozole

NHS ENGLAND

This public procurement record has 1 release in its history.

Planning

07 Sep 2021 at 17:59

Market Engagement Notice
Summary of the contracting process

The NHS England is initiating a tender process for a Licence Variation concerning Anastrozole, as indicated in their title "Prior Information Notice - Licence Variation for Anastrozole." This procurement falls under the pharmaceutical products category and is located in Runcorn, England. Currently, the process is in the planning stage, with the engagement end date set for 24th September 2021 at 12:00 noon. Interested organisations are encouraged to register their interest and seek further details via the provided contact point, Liz Fleetwood.

This tender presents a strategic opportunity for businesses involved in pharmaceutical services, particularly those with expertise in regulatory submissions and market authorisation processes. Companies that specialise in preparing licensing dossiers and possess the capability to navigate regulatory frameworks would be particularly well-suited to compete for this opportunity. Engaging in this process not only allows businesses to contribute to critical healthcare advancements but also positions them to expand their market presence through collaboration with NHS England.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Prior Information Notice - Licence Variation for Anastrozole

Notice Description

The Medicines Repurposing Programme has been established by NHS England and NHS Improvement (NHSE/I, the "Authority") to identify and pursue opportunities to strengthen the evidence base, licensing, supply, cost-effectiveness and equitable adoption of medicines used outside of their original marketing authorisation. The Programme is jointly sponsored by NHSE/I, the Department of Health and Social Care (DHSC), Medicines and Healthcare products Regulatory Agency (MHRA), National Institute for Health and Care Excellence (NICE), and National Institute for Health Research (NIHR). Further details can be found at: https://www.england.nhs.uk/medicines-2/medicines-repurposing-programme/ The Medicines Repurposing Programme is inviting those interested organisations to express an interest to seek a major (type II) MHRA Marketing Authorisation variation for anastrozole. The variation is to add a new indication to the current licence using published evidence. The selected company (the "Bidder") would need to prepare a dossier for the MHRA, apply for the licence variation, and if granted update their licence, Summary of Product Characteristics and patient information leaflet with the new indication and related data, according to the regulatory review. Interested organisations can access the PIN and register their interest here https://health-family.force.com/s/Welcome We will also be making time available for individual organisation discussions with NHSEI between 13th and 24th September 2021 should this be considered helpful. Once registered, please contact liz.fleetwood1@nhs.net with your availability. Deadline is 24th September @ 12:00noon

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-5a13f484-da40-451c-a6e6-d0b5fce23bf0
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/5a66b02a-b3f6-4f9d-876e-e71c5cd285fe
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
Market Engagement Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
7 Sep 20214 years ago
Submission Deadline
Not specified
Future Notice Date
24 Sep 2021Expired
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Planning
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS ENGLAND
Contact Name
Liz Fleetwood
Contact Email
liz.fleetwood1@nhs.net
Contact Phone
Not specified

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Post Town
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-5a13f484-da40-451c-a6e6-d0b5fce23bf0-2021-09-07T18:59:52+01:00",
    "date": "2021-09-07T18:59:52+01:00",
    "ocid": "ocds-b5fd17-5a13f484-da40-451c-a6e6-d0b5fce23bf0",
    "language": "en",
    "initiationType": "tender",
    "title": "Prior Information Notice - Licence Variation for Anastrozole",
    "planning": {
        "milestones": [
            {
                "id": "1",
                "title": "Engagement end date",
                "type": "engagement",
                "dueDate": "2021-09-24T23:59:59+01:00"
            }
        ],
        "documents": [
            {
                "id": "1",
                "documentType": "marketEngagementNotice",
                "description": "Early engagement notice on Contracts Finder",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/5a66b02a-b3f6-4f9d-876e-e71c5cd285fe",
                "datePublished": "2021-09-07T18:59:51+01:00",
                "format": "text/html",
                "language": "en"
            }
        ]
    },
    "tender": {
        "id": "CF-0339700D0O000000rwimUAA1",
        "title": "Prior Information Notice - Licence Variation for Anastrozole",
        "description": "The Medicines Repurposing Programme has been established by NHS England and NHS Improvement (NHSE/I, the \"Authority\") to identify and pursue opportunities to strengthen the evidence base, licensing, supply, cost-effectiveness and equitable adoption of medicines used outside of their original marketing authorisation. The Programme is jointly sponsored by NHSE/I, the Department of Health and Social Care (DHSC), Medicines and Healthcare products Regulatory Agency (MHRA), National Institute for Health and Care Excellence (NICE), and National Institute for Health Research (NIHR). Further details can be found at: https://www.england.nhs.uk/medicines-2/medicines-repurposing-programme/ The Medicines Repurposing Programme is inviting those interested organisations to express an interest to seek a major (type II) MHRA Marketing Authorisation variation for anastrozole. The variation is to add a new indication to the current licence using published evidence. The selected company (the \"Bidder\") would need to prepare a dossier for the MHRA, apply for the licence variation, and if granted update their licence, Summary of Product Characteristics and patient information leaflet with the new indication and related data, according to the regulatory review. Interested organisations can access the PIN and register their interest here https://health-family.force.com/s/Welcome We will also be making time available for individual organisation discussions with NHSEI between 13th and 24th September 2021 should this be considered helpful. Once registered, please contact liz.fleetwood1@nhs.net with your availability. Deadline is 24th September @ 12:00noon",
        "status": "planning",
        "classification": {
            "scheme": "CPV",
            "id": "33600000",
            "description": "Pharmaceutical products"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "postalCode": "WA7 2ES"
                    },
                    {
                        "region": "England",
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "suitability": {
            "sme": false,
            "vcse": false
        },
        "mainProcurementCategory": "services"
    },
    "parties": [
        {
            "id": "GB-CFS-156761",
            "name": "NHS England",
            "identifier": {
                "legalName": "NHS England"
            },
            "address": {
                "streetAddress": "Rutland House",
                "locality": "Runcorn",
                "postalCode": "WA7 2ES",
                "countryName": "GB"
            },
            "contactPoint": {
                "name": "Liz Fleetwood",
                "email": "liz.fleetwood1@nhs.net"
            },
            "roles": [
                "buyer"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-156761",
        "name": "NHS England"
    }
}